Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J KEATING

Showing results (351-360 of 1,115) with videos related to

Pageof 112
Sort By:
Journal of Neurochemistry|November 9, 2012
RCAN1 regulates vesicle recycling and quantal release kinetics via effects on calcineurin activityMark P Zanin, Kimberly D Mackenzie, Heshan Peiris, et al.
Cancer Treatment Reports|April 1, 1983
Phase II trial of mitoxantrone in refractory acute leukemiaE H Estey, M J Keating, K B McCredie, et al.
Cancer Treatment Reports|January 1, 1981
Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adultsB S Yap, K B McCredie, M J Keating, et al.
Bulletin Du Cancer|January 1, 1980
Knowledge acquisition from historical data: application to breast cancer patientsE A Gehan, T L Smith, A U Buzdar, et al.
Cancer Treatment Reports|May 1, 1981
Phase I--II study of 3-deazauridine in adults with acute leukemiaB S Yap, K B McCredie, M J Keating, et al.
Leukemia|September 30, 2005
Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cellsR-H Xu, H Pelicano, H Zhang, et al.
Leukemia & Lymphoma|April 10, 2008
Protein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicatorsZhifeng Yu, Baohua Sun, Hagop M Kantarjian, et al.
Transfusion|November 1, 1989
Red blood cell mass in autologous and homologous blood units. Implications for risk/benefit assessment of autologous blood crossover and directed blood transfusionL T Goodnough, J R Bravo, Y S Hsueh, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
Three newly approved drugs for chronic lymphocytic leukemia: incorporating ibrutinib, idelalisib, and obinutuzumab into clinical practiceDavid S Sanford, William G Wierda, Jan A Burger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
The characteristics and outcome of patients with late relapse acute myelogenous leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Pageof 112

Showing results (351-360 of 1,115) with videos related to

Sort By:
Pageof 112
Journal of Neurochemistry|November 9, 2012
RCAN1 regulates vesicle recycling and quantal release kinetics via effects on calcineurin activityMark P Zanin, Kimberly D Mackenzie, Heshan Peiris, et al.
Cancer Treatment Reports|April 1, 1983
Phase II trial of mitoxantrone in refractory acute leukemiaE H Estey, M J Keating, K B McCredie, et al.
Cancer Treatment Reports|January 1, 1981
Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adultsB S Yap, K B McCredie, M J Keating, et al.
Bulletin Du Cancer|January 1, 1980
Knowledge acquisition from historical data: application to breast cancer patientsE A Gehan, T L Smith, A U Buzdar, et al.
Cancer Treatment Reports|May 1, 1981
Phase I--II study of 3-deazauridine in adults with acute leukemiaB S Yap, K B McCredie, M J Keating, et al.
Leukemia|September 30, 2005
Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cellsR-H Xu, H Pelicano, H Zhang, et al.
Leukemia & Lymphoma|April 10, 2008
Protein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicatorsZhifeng Yu, Baohua Sun, Hagop M Kantarjian, et al.
Transfusion|November 1, 1989
Red blood cell mass in autologous and homologous blood units. Implications for risk/benefit assessment of autologous blood crossover and directed blood transfusionL T Goodnough, J R Bravo, Y S Hsueh, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
Three newly approved drugs for chronic lymphocytic leukemia: incorporating ibrutinib, idelalisib, and obinutuzumab into clinical practiceDavid S Sanford, William G Wierda, Jan A Burger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
The characteristics and outcome of patients with late relapse acute myelogenous leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Pageof 112